1. Detection of circulating tumor cells as therapeutic markers in patients with penile squamous cell carcinoma
- Author
-
Chin-Li Chen, En Meng, Dah-Shyong Yu, Ming-Hsin Yang, Guang-Huan Sun, Yung-Ning Yang, Sun-Yran Chang, Ting Xu, Tai-Lung Cha, Chien-Chang Kao, Sheng-Tang Wu, Shu-Yu Liu, Yi-Ta Tsai, and Chih-Wei Tsao
- Subjects
Aged, 80 and over ,Male ,Pathology ,medicine.medical_specialty ,medicine.diagnostic_test ,Cluster of differentiation ,Penile squamous cell carcinoma ,business.industry ,Significant difference ,General Medicine ,Neoplastic Cells, Circulating ,Immunofluorescence ,Cell morphology ,Dissection ,Circulating tumor cell ,Biomarkers, Tumor ,Carcinoma, Squamous Cell ,Humans ,Medicine ,In patient ,business ,Penile Neoplasms ,Aged - Abstract
BACKGROUND This study aimed to investigate the presence of circulating tumor cells (CTCs) in patients with penile squamous cell carcinoma (PSCC). METHODS CTCs were isolated from 14 patients with PSCC, 6 patients with balanoposthitis, and 6 healthy individuals. CTCs were enriched based on cell surface markers and filtered through the IsoFlux device, followed by identification according to cell morphology and immunofluorescence studies. RESULTS CTCs were found in all PSCC blood samples, but not in balanoposthitis samples and samples from healthy individuals. Immunofluorescence studies confirmed the tumor origin. When the patients with PSCC were stratified according to metastatic inguinal lymph node status, a statistically significant difference was observed in the number of detected CTCs. CONCLUSION Our study showed that CTCs in PSCC may represent a valuable marker for differentiating PSCC from other tumors. Based on the correlation with some clinical parameters, CTC analysis is possibly relevant for non-invasive monitoring of disease progression and prognosis. The results also suggested a potential role of CTCs in preventing overtreatment, such as inguinal lymph node dissection.
- Published
- 2021
- Full Text
- View/download PDF